THE DIRECT ANSWER

A compounded prescription is not an FDA-approved drug product. Compounding can address certain individual medical needs, but the reason, legal conditions, pharmacy, and exact preparation matter. Ask your Bradenton clinician to explain those details rather than accepting a broad claim that a compounded product is an approved generic.

What is different about compounding?

Compounding involves preparing a medication to meet a patient’s medical need. FDA explains that compounded drugs do not receive the agency’s premarket approval review. This does not mean all compounding is unlawful; it means the product has a different regulatory pathway and should be discussed accurately.

Ask which approved alternatives were considered and what patient-specific need the proposed preparation addresses. The response should concern your medical circumstances, not just a promotional claim.

Sources: FDA: compounding questions and answers

Check the prescription and pharmacy together

Request the legal name of the dispensing pharmacy, a way to reach the pharmacist, and the exact preparation being prescribed. Verify the pharmacy through the appropriate state licensing authority. A storefront name on a clinic website may differ from the legal pharmacy name on a prescription label.

If a label or shipment does not match what the practice said you would receive, contact the prescriber and pharmacist before using it. Do not guess that a different name or formulation is equivalent.

Sources: Florida Department of Health: verify a pharmacy license · FDA BeSafeRx: considering an online pharmacy · FDA: concerns with unapproved GLP-1 drugs

Questions specifically for compounded GLP-1 products

FDA describes concerns involving dosing errors, fraudulent labels, and some semaglutide salt forms. Those concerns make product identity and clinical follow-up important; they do not justify treating every preparation or every route as interchangeable.

  • Why is the approved product inappropriate for my individual need?
  • What active ingredient and formulation are being supplied?
  • Who prepared and dispensed the medication?
  • Who explains the label and answers questions?
  • What should I do if packaging, storage, or labeling seems wrong?

Sources: FDA: concerns with unapproved GLP-1 drugs

Keep a record of the decision

Retain the prescription details, pharmacy contact, written instructions, and your itemized quote. Ask how records can be shared with the clinician who already manages your health. A documented explanation makes it easier to revisit a decision if the available products, medical needs, or regulatory guidance changes.

Common questions

Is a compounded peptide an FDA-approved generic?

No. Compounding and approval of a generic drug are different regulatory categories.

Are all compounded prescriptions illegal?

No. Compounding is permitted under defined conditions. The prescriber and pharmacist should explain how the proposed preparation meets the applicable requirements.

Does a state pharmacy license guarantee the proposed treatment is right for me?

No. The license verifies a licensing fact. The clinical reason, exact product, evidence, and individual suitability require separate assessment.